TrialReader


Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes

NCT06174129 — Completed, 427 participants, Burapha University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes: A Case-Control Study

RegistryNCT06174129
StatusCompleted
Study typeObservational
Enrollment427 (Actual)
SponsorBurapha University (Other)
ConditionsAtrial Fibrillation, Type 2 Diabetes
InterventionsRoutine examinations (Other)
Datesstart 2022-06-01, primary completion 2023-06-30, completion 2023-07-31, first posted 2023-12-18, last updated 2023-12-18
Locations1 site in Thailand

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Atrial Fibrillation All trials for Type 2 Diabetes All trials of Routine examinations

-Summary

This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Type 2 diabetes patients with atrial fibrillationOther: Routine examinationsThe 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.
Type 2 diabetes patients without atrial fibrillationOther: Routine examinationsThe 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.
  • Routine examinations (Other): Electrocardiography and clinical parameters examinations, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications

+Outcome measures

Primary outcomes

  • Prevalence of atrial fibrillation [June 2022 and June 2023]: Prevalence of atrial fibrillation in patients with type 2 diabetes
  • Factors associated with atrial fibrillation [June 2022 and June 2023]: Factors associated with atrial fibrillation in patients with type 2 diabetes, including age, hypertension, heart failure, thyroid disease, type 2 diabetes duration, body mass index, estimated glomerular filtration rate, glycated hemoglobin, presence of albuminuria, and use of diuretic medications

+Eligibility

Sex: All

Inclusion Criteria:

* Outpatients with type 2 diabetes who visited the medical clinic between June 2022 and June 2023

Exclusion Criteria:

* Patients with missing information on the urinary albumin value and electrocardiograms at the latest date

+Locations (1)

FacilityCityCountryStatus
Burapha University HospitalMueang, Changwat Chon BuriThailand

My Notes